Add to watchlist
$75.48
Last updated:08/04/2021
MRK: NYSE
Merck & Co., Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health segments. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, v… Show more

Dividend yield
3.27%
$2.47 anually

3y growth is 12.74%– Yield is 52% higher than average in Health Care sector

P/E ratio
34.37x
vs. 12.42x forward

Price is 34.37x times more than EPS $2.2 which eaquals $75.48

Payout ratio
112.54%
Yearly

112.54% of earnings is used as dividends.

CASH payout ratio

Last quarter

Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
MRK dividends
Create free account to unlock
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Stock exposure in ETFs
ETF
Percentage of ETF
Become a premium member and see all 67 ETFs that include this stock
Company profile
CEO
Mr. Robert M. Davis
Market capitalization
Mega (191.12B)
MRK price history